AVCNF
Price
$0.19
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
Capitalization
22.7M
Intraday BUY SELL Signals
BSPK
Price
$0.15
Change
+$0.02 (+15.38%)
Updated
Nov 12 closing price
Capitalization
1.6M
Intraday BUY SELL Signals
Interact to see
Advertisement

AVCNF vs BSPK

Header iconAVCNF vs BSPK Comparison
Open Charts AVCNF vs BSPKBanner chart's image
Avicanna
Price$0.19
Change-$0.00 (-0.00%)
Volume$41.9K
Capitalization22.7M
Bespoke Extracts
Price$0.15
Change+$0.02 (+15.38%)
Volume$111
Capitalization1.6M
AVCNF vs BSPK Comparison Chart in %
AVCNF
Daily Signal:
Gain/Loss:
BSPK
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AVCNF vs. BSPK commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVCNF is a Hold and BSPK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (AVCNF: $0.19 vs. BSPK: $0.15)
Brand notoriety: AVCNF and BSPK are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AVCNF: 90% vs. BSPK: 2%
Market capitalization -- AVCNF: $22.7M vs. BSPK: $1.6M
AVCNF [@Pharmaceuticals: Generic] is valued at $22.7M. BSPK’s [@Pharmaceuticals: Generic] market capitalization is $1.6M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVCNF’s FA Score shows that 0 FA rating(s) are green whileBSPK’s FA Score has 0 green FA rating(s).

  • AVCNF’s FA Score: 0 green, 5 red.
  • BSPK’s FA Score: 0 green, 5 red.
According to our system of comparison, both AVCNF and BSPK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVCNF’s TA Score shows that 5 TA indicator(s) are bullish while BSPK’s TA Score has 3 bullish TA indicator(s).

  • AVCNF’s TA Score: 5 bullish, 4 bearish.
  • BSPK’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AVCNF is a better buy in the short-term than BSPK.

Price Growth

AVCNF (@Pharmaceuticals: Generic) experienced а +9.89% price change this week, while BSPK (@Pharmaceuticals: Generic) price change was +16.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.08%. For the same industry, the average monthly price growth was -3.24%, and the average quarterly price growth was +32.16%.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVCNF($22.7M) has a higher market cap than BSPK($1.6M). BSPK YTD gains are higher at: 150.000 vs. AVCNF (-4.041). AVCNF has higher annual earnings (EBITDA): -495.6K vs. BSPK (-767.07K). AVCNF has more cash in the bank: 208K vs. BSPK (1.36K). AVCNF has less debt than BSPK: AVCNF (37.1K) vs BSPK (1.46M). AVCNF has higher revenues than BSPK: AVCNF (25.4M) vs BSPK (1.23M).
AVCNFBSPKAVCNF / BSPK
Capitalization22.7M1.6M1,418%
EBITDA-495.6K-767.07K65%
Gain YTD-4.041150.000-3%
P/E RatioN/AN/A-
Revenue25.4M1.23M2,060%
Total Cash208K1.36K15,260%
Total Debt37.1K1.46M3%
FUNDAMENTALS RATINGS
AVCNF vs BSPK: Fundamental Ratings
AVCNF
BSPK
OUTLOOK RATING
1..100
8121
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
5965
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
28n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVCNF's Valuation (68) in the null industry is in the same range as BSPK (96). This means that AVCNF’s stock grew similarly to BSPK’s over the last 12 months.

AVCNF's Profit vs Risk Rating (100) in the null industry is in the same range as BSPK (100). This means that AVCNF’s stock grew similarly to BSPK’s over the last 12 months.

AVCNF's SMR Rating (98) in the null industry is in the same range as BSPK (100). This means that AVCNF’s stock grew similarly to BSPK’s over the last 12 months.

AVCNF's Price Growth Rating (59) in the null industry is in the same range as BSPK (65). This means that AVCNF’s stock grew similarly to BSPK’s over the last 12 months.

AVCNF's P/E Growth Rating (100) in the null industry is in the same range as BSPK (100). This means that AVCNF’s stock grew similarly to BSPK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVCNFBSPK
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
AVCNF
Daily Signal:
Gain/Loss:
BSPK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD1.210.03
+2.54%
Auddia Inc
UNM77.341.01
+1.32%
Unum Group
AAM10.63-0.04
-0.37%
AA Mission Acquisition Corp
XRAY10.84-0.14
-1.28%
DENTSPLY SIRONA
PSQH1.77-0.03
-1.67%
PSQ Holdings

AVCNF and

Correlation & Price change

A.I.dvisor tells us that AVCNF and PRFX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCNF and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCNF
1D Price
Change %
AVCNF100%
+3.07%
PRFX - AVCNF
20%
Poorly correlated
+9.26%
ARSUF - AVCNF
12%
Poorly correlated
N/A
BSPK - AVCNF
9%
Poorly correlated
+15.15%
APNHY - AVCNF
7%
Poorly correlated
N/A
BKUH - AVCNF
5%
Poorly correlated
N/A
More

BSPK and

Correlation & Price change

A.I.dvisor tells us that BSPK and AVCNF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSPK and AVCNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSPK
1D Price
Change %
BSPK100%
+15.15%
AVCNF - BSPK
9%
Poorly correlated
+3.07%
CHSYF - BSPK
9%
Poorly correlated
N/A
CAIHF - BSPK
4%
Poorly correlated
N/A
BOIRF - BSPK
4%
Poorly correlated
N/A
ARSUF - BSPK
2%
Poorly correlated
N/A
More